A carregar...
New compounds in the management of venous thromboembolism after orthopedic surgery: focus on rivaroxaban
Rivaroxaban (Xarelto(®)) is a member of a new class of oral, direct (antithrombinindependent) factor Xa inhibitors, which restrict thrombin generation both in vitro and in vivo. After oral administration the absorption is near 100%, the bioavailability is near 80%, and the elimination half-life is 5...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2597756/ https://ncbi.nlm.nih.gov/pubmed/19066002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|